Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling

Table 1

Correlation of clinicopathological features with ITGA9 expression.

Variable		ITGA9 ()
	High	Low	value
Age
≤50 years	63	40	0.081
>50 years	72	27
Gender
Female	14	14	0.042
Male	121	53
Alpha-fetoprotein
≤20 ng/ml	53	16	0.025
>20 ng/ml	80	51
Gamma-glutamyltransferase
≤50 (U/l)	48	27	0.536
>50 (U/l)	86	40
Liver cirrhosis
Yes	116	60	0.649
No	19	7
Tumor multiplicity
Single	109	59	0.191
Multiple	26	8
Tumor satellite
Yes	42	19	0.688
No	93	48
Tumor encapsulation
Incomplete	87	50	0.186
Complete	46	17
Tumor thrombosis			0.007
Yes	22	22
No	113	45
Tumor differentiation
I	3	0	0.056
II	55	17
III	76	50
Vascular invasion
Yes	32	25	0.043
No	103	42
Tumor size
≤5 cm	76	25	0.011
>5 cm	59	42
TNM stage
I	83	35	0.027
I	17	6
III	34	25

(; Pearson’s χ² test).